ResMed (RMD)

Cost of Revenue

$602.43M

Quarterly · Period ending: · USD

RMD logo

RMD Cost of Revenue

Latest reported$602.43M
RMD Quarterly Cost of Revenue ($0.00 → $602.43M)
High-resolution chart · PNG

RMD cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

ResMed Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
20,988,000
11,792,000
9,566,000
8,031,000
8,623,000
8,192,000
7,100,000
6,800,000
7,200,000
6,800,000
5,900,000
5,100,000
5,500,000
4,900,000
4,500,000
4,500,000
4,800,000
4,400,000
4,100,000
4,400,000
4,400,000
4,600,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.